Full-Time

Senior Study Start Up Lead

Posted on 9/3/2025

ProPharma Group

ProPharma Group

1,001-5,000 employees

Regulatory sciences consultant for life sciences

No salary listed

United Kingdom + 1 more

More locations: United States

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Word/Pages/Docs
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Excellent verbal and written communication skills
  • Must be able to prioritize and manage multiple projects and show attention to detail
  • Comprehensive knowledge and understanding of ICH-GCP
  • Working knowledge and experience in Microsoft Office (e.g., Word, Excel, Project)
  • Experience with working in eTMF and CTMS within the framework of the study start up responsibilities
  • Bachelor’s degree required, preferably in life sciences, or related discipline
  • 4+ years’ experience within a Clinical Research, Site Activation, and Study Start Up
Responsibilities
  • Updates knowledge on related regulatory requirements, ensures adherence and compliance with local regulations and internal procedures
  • Manages both the technical and operational aspects of site identification, site feasibility and site activation for assigned projects, site contracts, and project teams
  • Maintains and analyzes study start-up data (metrics) on assigned studies, ensuring optimal efficiency to reduce start-up timelines and identify opportunities for continuous improvement
  • Executes all start-up activities prior to site activation on assigned studies, according to standards and aligned with study/project requirements and timelines
  • Prepares country level Informed Consent Form (ICF) and obtains ethics committees' and local regulatory authorities' approval
  • Prepares ongoing submissions, amendments and periodic notifications required by ethics committees and regulatory authorities as needed within the country
  • Partners with other study team members to provide guidance on regulatory/ethics requirements, to track and drive site activations and trial amendments submissions, by regularly reviewing and monitoring status of submissions/activations
  • Supports drug label preparation and approval (as local label representative) for studies in collaboration with local Regulatory /Quality department, as required
  • In collaboration with Clinical Site Manager, identifies and tracks new investigator sites performing feasibility, as applicable, and develops and supports effective patient recruitment and retention practices, as required
  • Responsible for study budget and contracts negotiation in collaboration with Legal team, as required and ensures compliance with Fair Market Value (FMV) in the country
  • Other duties as assigned

ProPharma Group provides regulatory sciences consulting and related services for drugs, biologics, medical devices, and diagnostics on a global scale. Its offerings cover the full lifecycle, from early development and clinical trials to regulatory approval and post-market activities. The company’s services include regulatory sciences, clinical research, quality and compliance, pharmacovigilance, medical information, and R&D technology, delivered by a team of over 2,500 professionals with more than 20 years of operation. ProPharma Group differentiates itself by providing expert, end-to-end regulatory and life sciences solutions across multiple product types and stages, helping pharmaceutical, biotechnology, and medical device companies navigate complex regulatory and compliance challenges. The goal is to help clients bring safe and compliant products to market efficiently while maintaining ongoing lifecycle support.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Raleigh, North Carolina

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • Hyderabad office opened November 2025 taps India's $130B pharma growth by 2030.
  • Dawn Sherman appointed CEO September 2024 drives global expansion strategy.
  • CF Box partnership revolutionizes cell/gene therapy manufacturing support.

What critics are saying

  • IQVIA undercuts prices, eroding ProPharma's pharmacovigilance share in 12-24 months.
  • Parexel acquisition intensifies clinical research competition in 6-12 months.
  • FDA AI tools automate 30% of submissions, reducing consulting demand in 18-36 months.

What makes ProPharma Group unique

  • ProPharma delivers end-to-end regulatory sciences across drugs, biologics, and devices.
  • Over 2,500 professionals provide pharmacovigilance and clinical research expertise.
  • Acquired Clinres Farmacija in 2024 to enhance CRO capabilities in Europe.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

24%
Pagal Parrot Media Private Limited
Dec 11th, 2025
ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands operations with new office in Hyderabad. Modern workspace supports continued growth and innovationRALEIGH, N.C., Dec. 11, 2025 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official inauguration of its new office in Hyderabad, India, on November 17, 2025. Strategically located in Mindspace, at the heart of Hyderabad's technology corridor (HITEC City/Madhapur), the new office places ProPharma among the world's leading Global Capability Centers (GCCs) in the pharmaceutical industry. Mindspace is also the first commercial business park in Hyderabad to receive a Gold rating from the Indian Green Building Council (IGBC). The prominent placement of the ProPharma logo atop the building underscores the company's growing presence and brand visibility in India.The expansion supports ProPharma's continued growth trajectory by providing capacity for additional team members across multiple service lines and creating a modern, collaborative environment designed to inspire innovation and connection. More than 70 employees participated in the inaugural celebration."This milestone represents an important step forward in ProPharma's global expansion," said Jason DeGoes, President, ProPharma. "Our new Hyderabad office strengthens our ability to deliver high-quality, integrated solutions for our clients around the world and reflects our commitment to building an exceptional environment for our teams.""We're proud to establish a world-class workspace in Hyderabad - one designed to foster creativity, efficiency, and collaboration," added Pavan Hemadri, Director of Business Operations, ProPharma. "This move enhances our ability to attract top local talent and better serve our clients across regulatory, clinical, and compliance domains."The new state-of-the-art facility features open, collaborative workspaces aligned with ProPharma's global culture of innovation and operational excellence. It also underscores ProPharma's long-term investment in India as a key hub supporting its worldwide operations.About ProPharmaFor the last 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, FSP solutions, and digital transformation, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate its partners' most high-profile drug and device programs. For more information about ProPharma, please visit propharmagroup.com.About Odyssey Investment PartnersOdyssey Investment Partners is a leading private equity investment firm with more than a 25-year history of partnering with skilled managers to transform middle-market companies into more efficient and diversified businesses with strong growth profiles. Odyssey makes majority-controlled investments in industries with a long-term positive outlook and favorable secular trends. For further information about Odyssey, please visit odysseyinvestment.com.Logo - https://www.pagalparrot.com/wp-content/uploads/2025/12/ProPharma_Group_Logo.jpg View original content:https://www.prnewswire.co.uk/news-releases/propharma-expands-operations-with-new-office-in-hyderabad-302638474.html

CNHI
Oct 21st, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer

RALEIGH, N.C., Oct. 21, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced that Brian Tuttle has been named Chief Financial Officer.

Kilgore News Herald
Oct 9th, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

RALEIGH, N.C., Oct. 9, 2024 /PRNewswire/ - ProPharma, a leading global provider of regulatory, clinical, and compliance services for the life sciences industry, is pleased to announce it has won the prestigious CPHI Pharma Award for Regulatory and Compliance.

PR Newswire
Sep 30th, 2024
ProPharma Names Dawn Sherman Chief Executive Officer

RALEIGH, N.C., Sept. 30, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced that Dawn Sherman has been appointed Chief Executive Officer.

GlobalData
Sep 24th, 2024
Clinical Trials Arena Excellence Awards 2024: ProPharma

ProPharma, a global research consulting company headquartered in the US, has won two awards in the 2024 Clinical Trials Arena Excellence Awards, in the Business Expansion and M&A categories, celebrating its acquisition of the Croatia-based contract research organization (CRO), Clinres Farmacija.

INACTIVE